Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France.
about
Population structure of invasive Streptococcus pneumoniae isolates among Alaskan children in the conjugate vaccine era, 2001 to 2013.An outbreak of pneumococcal meningitis among older children (≥5 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana.Rising total costs and mortality rates associated with admissions due to COPD exacerbations.Streptococcus pneumoniae serotype 19A: Worldwide epidemiology.Streptococcus pneumoniae antimicrobial resistance decreased in the Helsinki Metropolitan Area after routine 10-valent pneumococcal conjugate vaccination of infants in Finland.Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children.Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States.Use of Multiplex Quantitative PCR To Evaluate the Impact of Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Colonization in African Children.Evaluation of protective efficacy of selected immunodominant B-cell epitopes within virulent surface proteins of S. Pneumoniae.Pneumococcal whole-cell and protein-based vaccines: changing the paradigm.Reply to Gilchrist et al. and to MusherEffects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010-2017
P2860
Q30151859-BDF94F95-5B63-4011-9630-F44B088E29A6Q36166629-DAAF18A3-3BEC-4C58-BEE5-6492128A9619Q37414845-E0538D62-394C-48DD-8874-EC57EBA6FFD6Q38637072-8A20F17A-5ED4-4585-8A4F-B3BAB04824CAQ38726698-76966A66-5146-4087-8900-67FC0AFFF23DQ40401092-8DC25102-B379-42F3-B4DA-284EE27E2EBBQ40450492-57FCE6E0-DAD8-4170-B6C0-775AA28066FCQ44521723-3469965F-D8DB-47F0-8FE1-3A1983A8C994Q47269510-A92131D1-9E5D-4FC9-9F13-99C6660920B9Q47410739-B1D07350-6E43-4E20-A296-F7E94FA065D2Q56977542-B5A9F32D-9826-4F80-BA0D-5C0727748538Q58550643-83E24DE2-BFA0-4151-BC64-E88BDD4EC52D
P2860
Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France.
description
2016 nî lūn-bûn
@nan
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
name
Insight Into Resistance Phenot ...... cine Implementation in France.
@ast
Insight Into Resistance Phenot ...... cine Implementation in France.
@en
type
label
Insight Into Resistance Phenot ...... cine Implementation in France.
@ast
Insight Into Resistance Phenot ...... cine Implementation in France.
@en
prefLabel
Insight Into Resistance Phenot ...... cine Implementation in France.
@ast
Insight Into Resistance Phenot ...... cine Implementation in France.
@en
P2093
P2860
P356
P1476
Insight Into Resistance Phenot ...... cine Implementation in France.
@en
P2093
Agnès Lepoutre
Claire Janoir
Emmanuelle Varon
Laurent Gutmann
P2860
P304
P356
10.1093/OFID/OFW020
P407
P577
2016-01-01T00:00:00Z